The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N1,N3-bis(4-carbamimidoylphenethyl)malonamide ID: ALA5265971
Max Phase: Preclinical
Molecular Formula: C21H26N6O2
Molecular Weight: 394.48
Associated Items:
Names and Identifiers Canonical SMILES: N=C(N)c1ccc(CCNC(=O)CC(=O)NCCc2ccc(C(=N)N)cc2)cc1
Standard InChI: InChI=1S/C21H26N6O2/c22-20(23)16-5-1-14(2-6-16)9-11-26-18(28)13-19(29)27-12-10-15-3-7-17(8-4-15)21(24)25/h1-8H,9-13H2,(H3,22,23)(H3,24,25)(H,26,28)(H,27,29)
Standard InChI Key: UMWOKGIVZJWFOR-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 30 0 0 0 0 0 0 0 0999 V2000
-5.0004 0.0007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2858 0.4130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5739 0.0010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5739 -0.8240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2840 -1.2358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0004 -0.8277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8592 -1.2366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1446 -0.8240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4299 -1.2366 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7153 -0.8240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0007 -1.2366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7153 0.0010 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7139 -0.8240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4285 -1.2366 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7139 0.0010 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1431 -0.8240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8578 -1.2366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5724 -0.8240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5726 0.0011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2855 0.4118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0004 -0.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0019 -0.8219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2901 -1.2384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7150 0.4117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7150 1.2369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4296 -0.0008 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.7150 0.4133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4296 0.0007 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.7150 1.2384 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
10 12 2 0
11 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
16 17 1 0
17 18 1 0
19 18 2 0
20 19 1 0
21 20 2 0
22 21 1 0
23 22 2 0
18 23 1 0
21 24 1 0
24 25 2 0
24 26 1 0
1 27 1 0
27 28 1 0
27 29 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 394.48Molecular Weight (Monoisotopic): 394.2117AlogP: 0.66#Rotatable Bonds: 10Polar Surface Area: 157.94Molecular Species: BASEHBA: 4HBD: 6#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 8#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.23CX Basic pKa: 11.79CX LogP: 0.14CX LogD: -4.44Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.20Np Likeness Score: -0.26
References 1. Hammerschmidt SJ, Maus H, Weldert AC, Gütschow M, Kersten C.. (2023) Improving binding entropy by higher ligand symmetry? - A case study with human matriptase., 14 (5): [PMID:37252099 ] [10.1039/d3md00125c ]